Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cognitive Dysfunction × G(M1) Ganglioside × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiation Injuries 1 Gangliosidosis, GM1 1 Gangliosidoses 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

mazdutide 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Memantine 1 Hormones 1 G(M1) Ganglioside 1 Exercise 1 Donepezil 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04395339 2024-08-01

GLORY

Sun Yat-sen University

Phase 3 Terminated

Brain Neoplasms, Breast Neoplasms, Gangliosidoses, Radiation Injuries, Gangliosidosis, GM1, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡